JoVE Journal
Bioengineering
Bioengineering
È necessario avere un abbonamento a JoVE per visualizzare questo Contenuto.
Capitoli
Riepilogo
Biomaterials doped with Bone Morphogenetic Protein 2 (BMP2) have been used as a new therapeutic strategy to heal non-union bone fractures. To overcome side effects resulting from an uncontrollable release of the factor, we propose a new strategy to site-directly immobilize the factor, thus creating materials with improved osteogenic capabilities.